PFIZER INC Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31)
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) of $144.00 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeTax · last filed 2013-05-10
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $144.00M.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-12-31 was -$64.00M, a 150.00% decline year-over-year.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-09-30 was -$52.00M, a 120.80% decline year-over-year.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-07-01 was $133.00M.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2012 was -$98.00M, a 201.03% decline from fiscal 2011.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2011 was $97.00M, a 54.88% decline from fiscal 2010.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2010 was $215.00M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $144.00M 10-Q · filed 2013-05-10 | $80.00M derived: sum of 2 quarters · filed 2013-05-10 | $28.00M derived: sum of 3 quarters · filed 2013-05-10 | $161.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-12-31 | -$64.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$116.00M derived: sum of 2 quarters · filed 2013-02-28 | $17.00M derived: sum of 3 quarters · filed 2013-02-28 | -$98.00M 10-K · filed 2013-02-28 |
| 2012-09-30 | -$52.00M 10-Q · filed 2012-11-09 | $81.00M derived: sum of 2 quarters · filed 2012-11-09 | -$34.00M 10-Q · filed 2012-11-09 | $94.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-07-01 | $133.00M 10-Q · filed 2012-08-09 | $18.00M 10-Q · filed 2012-08-09 | $146.00M derived: sum of 3 quarters · filed 2013-05-10 | $396.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-04-01 | -$115.00M 10-Q · filed 2013-05-10 | $13.00M derived: sum of 2 quarters · filed 2013-05-10 | $263.00M derived: sum of 3 quarters · filed 2013-05-10 | $176.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $128.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $378.00M derived: sum of 2 quarters · filed 2013-02-28 | $291.00M derived: sum of 3 quarters · filed 2013-02-28 | $97.00M 10-K · filed 2013-02-28 |
| 2011-10-02 | $250.00M 10-Q · filed 2012-11-09 | $163.00M derived: sum of 2 quarters · filed 2012-11-09 | -$31.00M 10-Q · filed 2012-11-09 | |
| 2011-07-03 | -$87.00M 10-Q · filed 2012-08-09 | -$281.00M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $215.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |